Modified -galactosyl ceramides for staining and stimulating Natural Killer T cells
Details for Australian Patent Application No. 2007234753 (hide)
International Classifications
Event Publications
2 July 2009 Section 223 Application Allowed
The Scripps Research Institute; Brigham Young University; The University Of Chicago The time in which to enter the National Phase has been extended to 07 Feb 2009. Address for service in Australia - Mallesons Stephen Jaques Level 50 Bourke Place 600 Bourke Street Melbourne VIC 3000 2009
16 July 2009 PCT application entered the National Phase
PCT publication WO2007/118234 Priority application(s): WO2007/118234
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007234762-Spirocyclic heterocyclic derivatives and methods of their use
2007234751-System and method for facilitating foreign currency management
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser